Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
letter
. 2022 Oct 7:1. Online ahead of print. doi: 10.1007/s10354-022-00973-8

Response to R. Mungmumpuntipanip and V. Wiwantikit

Correspondence to “Post-SARS-CoV-2 vaccination COVID toes and fingers”

Uwe Wollina 1,✉
PMCID: PMC9542449  PMID: 36207559

Dear Editor,

I very much appreciate the interest the observation of post-SARS-CoV‑2 vaccination COVID toes and fingers has gained. R. Mungmumpuntipanip and V. Wiwantikit pointed to the important issue that before making a definitive diagnosis, other causes should be carefully ruled out. I completely agree. Dengue fever is the most frequent arboviral disease encountered in travelers, but global travel restrictions during the COVID-19 pandemic reduced this risk, at least in Europe [1].

The coinfection of patients with SARS-CoV‑2 and Dengue virus is a particular problem in tropical countries and the diseases may show an overlap of cutaneous symptoms. Dengue fever is therefore also an important differential diagnosis in COVID-19 disease [2].

Dengue fever, as suggested by R. Mungmumpuntipanip and V. Wiwantikit, is a common diagnosis in other parts of the, world but not in Saxony, in particular since both involved patients had never visited tropical countries. The Robert Koch Institute registered only 205 cases of Dengue fever in Germany in 2020 [3].

No symptoms or laboratory findings suggestive of another systemic infection were found. In our two patients, no other cause of COVID toes and fingers was evident apart from the vaccination against SARS-CoV‑2.

However, future climate change and the invasion of vectors such as Aedes may increase the risk of vector-borne diseases in Europe as well. Medical doctors should be aware of this [4].

Conflict of interest

U. Wollina declares that he has no competing interests.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Wilder-Smith A. Dengue during the COVID-19 pandemic. J Travel Med. 2021;28(8):taab183. doi: 10.1093/jtm/taab183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Polo-Martínez M, Campo-Jiménez R, Ariza-Arroyo A, Aparicio-Marenco D, Angulo-Romero H, Torres-Madrid C. Es posible la coinfección o un diagnóstico erróneo por dengue y COVID-19? Una revisión de reporte de casos [Is dengue and COVID-19 coinfection or misdiagnosis possible? A review on reported cases. Rev Chilena Infectol. 2022;39(2):167–173. doi: 10.4067/S0716-10182022000200167. [DOI] [PubMed] [Google Scholar]
  • 3.Robert-Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2020.. https://www.rki.de/DE/Content/Infekt/Jahrbuch/Jahrbuch_2020.pdf?__blob=publicationFile. Accessed 9 Sept 2022.
  • 4.Semenza JC, Paz S. Climate change and infectious disease in Europe: Impact, projection and adaptation. Lancet Reg Health Eur. 2021;9:100230. doi: 10.1016/j.lanepe.2021.100230. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Wiener Medizinische Wochenschrift (1946) are provided here courtesy of Nature Publishing Group

RESOURCES